iFCG yields unprecedented MRD negativity in CLL
FCR chemoimmunotherapy is most effective in the IGVH mutated, non-17p deletion chronic lymphocytic leukemia (CLL) patient subgroup. With the advent of novel drugs in the field however, Nitin Jain, MD,...
Author: VJHemOnc
Added: 09/21/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts